Medium impact
Barrett's Esophagus (CPB 0728, reviewed 2025-11-25)
Aetna·Effective Nov 25, 2025
Aetna's Barrett's Esophagus policy (CPB 0728, effective 2025-11-25) establishes clear medical necessity criteria for covered treatments: radiofrequency ablation for low-grade dysplasia with specific biopsy requirements, and five approved interventions (endoscopic mucosal resection, esophagectomy, fundoplication, photodynamic therapy, radiofrequency ablation) for high-grade dysplasia. The policy designates numerous emerging tests and techniques as experimental/investigational, including AI detection tools, biomarker panels, cryotherapy, and laser therapies, which are not covered.